RCW 70.225.070
141 words·~1 min read·
/wa/title-70/chapter-70-225/70-225-070·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(1)Test sites that may receive access to data in the prescription monitoring program under RCW 70.225.040 must be:
(a)Licensed by the department as a test site under chapter 70.42 RCW; and
(b)Certified as a drug testing laboratory by the United States department of health and human services, substance abuse and mental health services administration.
(2)Test sites may not:
(a)Charge a fee for accessing the prescription monitoring program;
(b)Store data accessed from the prescription drug monitoring program in any form, including, but not limited to, hard copies, electronic copies, or web/digital based copies of any kind. Such data may be used only to transmit to those entities listed in *RCW 70.255.040 (3)(a).
[ 2015 c 259 s 2 .]
Notes:
*Reviser's note: The reference to RCW 70.255.040 appears to be erroneous. RCW 70.225.040 was apparently intended.